Dr. Brown on Genetic Counseling for Breast and Ovarian Cancer

Video

Jubilee Brown, MD, obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

Jubilee Brown, MD, obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

With a multi-pronged approach that included physician and provider engagement and education, patient navigation, genetic counseling services, and telegenetics, there was an increase in the number of patients who were referred with ovarian cancer from 37% to 96% within a 2-year period.

This was then able to be reproduced for patients with breast cancer. Additionally, there was an increase in patients who were tested from 24% to over 50% in the same 2-year period, explains Brown.

Related Videos
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Don S. Dizon, MD
Rita Nanda, MD
Siddartha Yadav, MD, FACP
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
Nan Chen, MD
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center